tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

YMAB

Two new option listings and option delistings on September 23rd
The FlyTwo new option listings and option delistings on September 23rd
13d ago
YMAB
Y-Mabs Therapeutics Completes Merger with Perseus BidCo
PremiumCompany Announcements
Y-Mabs Therapeutics Completes Merger with Perseus BidCo
20d ago
8K
YMAB
Y-Mabs Therapeutics’ Phase 2 Trial: A Potential Breakthrough for Neuroblastoma Treatment
PremiumCompany Announcements
Y-Mabs Therapeutics’ Phase 2 Trial: A Potential Breakthrough for Neuroblastoma Treatment
29d ago
YMAB
Y-mAbs Therapeutics Reports Q2 Earnings and Acquisition
PremiumCompany Announcements
Y-mAbs Therapeutics Reports Q2 Earnings and Acquisition
2M ago
YMAB
Y-mAbs Therapeutics reports Q2 EPS (7c), consensus (25c)
PremiumThe Fly
Y-mAbs Therapeutics reports Q2 EPS (7c), consensus (25c)
2M ago
YMAB
Y-mAbs Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyY-mAbs Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
2M ago
YMAB
Y-mAbs Therapeutics downgraded to Perform from Outperform at Oppenheimer
Premium
The Fly
Y-mAbs Therapeutics downgraded to Perform from Outperform at Oppenheimer
2M ago
YMAB
Y-mAbs Therapeutics downgraded to Hold from Buy at Canaccord
Premium
The Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at Canaccord
2M ago
YMAB
Y-mAbs Therapeutics upgraded to Equal Weight from Underweight at Morgan Stanley
PremiumThe Fly
Y-mAbs Therapeutics upgraded to Equal Weight from Underweight at Morgan Stanley
2M ago
YMAB
Hold Rating Issued Amidst SERB Pharmaceuticals’ Acquisition of Y-mAbs Therapeutics
PremiumRatings
Hold Rating Issued Amidst SERB Pharmaceuticals’ Acquisition of Y-mAbs Therapeutics
2M ago
YMAB
Y-mAbs Therapeutics downgraded to Hold from Buy at Truist
PremiumThe Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at Truist
2M ago
YMAB
Y-mAbs Therapeutics downgraded to Hold from Buy at Brookline
PremiumThe Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at Brookline
2M ago
YMAB
Y-mAbs Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe FlyY-mAbs Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
2M ago
YMAB
Y-mAbs Therapeutics downgraded to Hold from Buy at Clear Street
Premium
The Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at Clear Street
2M ago
YMAB
Y-mAbs Therapeutics downgraded to Hold from Buy at JonesResearch
Premium
The Fly
Y-mAbs Therapeutics downgraded to Hold from Buy at JonesResearch
2M ago
YMAB
Palantir reports Q2 beat, Caterpillar posts mixed results: Morning Buzz
PremiumThe Fly
Palantir reports Q2 beat, Caterpillar posts mixed results: Morning Buzz
2M ago
W
IT
Y-mAbs Therapeutics downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Y-mAbs Therapeutics downgraded to Neutral from Outperform at Wedbush
2M ago
YMAB
Y-Mabs Therapeutics Announces Merger with SERB Pharmaceuticals
PremiumCompany Announcements
Y-Mabs Therapeutics Announces Merger with SERB Pharmaceuticals
2M ago
8K
YMAB
Y mAbs Therapeutics trading resumes
PremiumThe Fly
Y mAbs Therapeutics trading resumes
2M ago
YMAB
SERB to acquire Y-mAbs Therapeutics for $8.60 per share in cash
PremiumThe FlySERB to acquire Y-mAbs Therapeutics for $8.60 per share in cash
2M ago
YMAB
Y mAbs Therapeutics trading halted, news pending
Premium
The Fly
Y mAbs Therapeutics trading halted, news pending
2M ago
YMAB
Y-Mabs Therapeutics Elects New Director at Annual Meeting
Premium
Company Announcements
Y-Mabs Therapeutics Elects New Director at Annual Meeting
3M ago
8K
YMAB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >